Meseclazone, 5-Chlorosalicylic Acid and Acetylsalicvlic Acid

Summary

Meseclazone and its major metabolite, 5-chlorosalicylic acid (5-CSA) have been shown to possess anti-inflammatory, analgesic and antipyretic activity. The comparative effects of these compounds on platelet aggregation were evaluated in vitro and ex vitro with acetylsalicylic acid (ASA). in vitro, meseclazone and ASA exhibited almost identical inhibitory potency of secondary phase ADP aggregation while 5-CSA was less effective. Moreover, collagen aggregation was inhibited by all three agents: ASA > meseclazone > 5- CSA. Thrombin-induced aggregation was inhibited to approximately the same extent by 5- CSA and ASA while meseclazone was inactive. The in vitro effects on the release-inducing aggregants were confirmed by ex vitro experiments in rats. These demonstrated that ASA and meseclazone inhibited collagen-induced aggregation 1 and 4 hr after oral administration although ASA was three to four times more active. ASA, but not meseclazone, was still effective 24 hr after administration. Bleeding times in rats 1 and 4 hr following oral administration of meseclazone and ASA were not altered. It is concluded that meseclazone and/or 5-CSA inhibit in vitro and ex vitro platelet aggregation initiated by the release reaction similar to ASA and other non-steroidal anti-inflammatory drugs.

• References

• 1 Al-Mondhiry H, Marcus AJ, Spaet TH. 1970; On the mechanism of platelet function inhibition by acetylsalicylic acid. Proceedings of the Society for Experimental Biology and Medicine 133: 632
• 2 Born GV R. 1962; Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927
• 3 de Clerck F, Goossens J, Reneman R. 1976; Effects of anti-inflammatory, anticoagulant and vasoactive compounds on tail bleeding time, whole blood coagulation time and platelet retention by glass beads in rats. Thrombosis Research 8: 179
• 4 Edelson J, Douglas JF, Ludwig BJ, Schuster EB, Shahinian S. 1975; Absorption, distribution and metabolic fate of 7-chloro-2-methyl-3,3a-dihydro-2H,9H-isoxazolo [3,2-b] [1,3]- benzoxazin-9-one in rats, dogs and humans. Journal of Pharmaceutical Sciences 64: 1316
• 5 Evans G, Packham MA, Nishizawa EE, Mustard JF, Murphy EA. 1968; The effect of acetylsalicylic acid on platelet function. Journal of Experimental Medicine 128: 877
• 6 Fenichel RL, Dougherty JA, Alburn HE. 1974; Inhibition of platelet aggregation by 2-(p-chlorophenyl)-4-thiazoleacrylic acid (WY-23,049) - Comparison with acetylsalicylic acid. Biochemical Pharmacology 23: 3273
• 7 Fleischman AI, Bierenbaum ML, Stier A. 1976; The effect of aspirin on in vivo platelet function in humans. Thrombosis Research 8: 191
• 8 Hornstra G, ten Hoor F. 1975; The filtragometer: A new device for measuring platelet aggregation in venous blood of man. Thrombosis et Diathesis Haemorrhagica 34: 531
• 9 Macintyre DE, Gordon JL. 1975; Duration of aspirin’s effect on human platelet aggregation. Journal of Pharmacy and Pharmacology 27: 19 P
• 10 Macmillan DC. 1966; Secondary clumping effect in human citrated platelet-rich plasma produced by adenosine diphosphate and adrenaline. Nature 211: 140
• 11 Macmillan DC, Sim AK. 1970; A comparative study of platelet aggregation in man and laboratory animals. Thrombosis et Diathesis Haemorrhagica 24: 385
• 12 Minsker DH, Humes JL, Jordan PT, Kling PJ, Wolf GL. 1977. Prostaglandin synthetase inhibitors as antithrombotic agents. In: Silver MJ, Smith JB, Kocsis JJ. (eds) Prostaglandins in Hematology. Spectrum Publications; New York: p 331
• 13 Minsker DH, Jordan PT, Macmillan A. 1974. Inhibition of platelet aggregation by cyproheptadine. In: Sherry S, Scriabine A. (eds) Platelets and Thrombosis. University Park Press; Baltimore: p 161
• 14 Mustard JF, Packham MA. 1970; Factors influencing platelet function: Adhesion, release and aggregation. Pharmacological Reviews 22: 97
• 15 Mustard JF, Packham MA. 1975; Platelets, thrombosis and drugs. Drugs 9: 19
• 16 Nishizawa EE, Wynalda DJ, Suydam DE, Molony BA. 1973; Flurbiprofen, a new potent inhibitor of platelet aggregation. Thrombosis Research 3: 577
• 17 O’Brien JR. 1968; Effects of salicylates on human platelets. Lancet 1: 779
• 18 Okumura T, Jamieson GA. 1976; Platelet glycocalicin: A single receptor for platelet aggregation induced by thrombin or ristocetin. Thrombosis Research 8: 701
• 19 Packham MA, Kinlough-Rathbone RL, Reimers HJ, Scott S, Mustard JF. 1977. Mechanisms of platelet aggregation independent of adenosine diphosphate. In: Silver MJ, Smith JB, Kocsis JJ. (eds) Prostaglandins in Hematology. Spectrum Publications; New York: P 247
• 20 Packham MA, Mustard JF. 1969; The effect of pyrazole compounds on thrombin-induced platelet aggregation. Proceedings of the Society for Experimental Biology and Medicine 130: 72
• 21 Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyl AF, Hirsh J, Packham MA, Mustard JF. 1976; In vitro and in vivo functions of thrombin-treated platelets. Thrombosis and Haemostasis 35: 151
• 22 Renaud P, Godu J. 1970; Thrombosis prevention by acetylsalicylic acid in hyperlipemic rats. Canadian Medical Association Journal 103: 1037
• 23 Rosenberg FJ, Gimber-Phillips PE, Groblewski GE, Davison C, Phillips DK, Goralnick SJ, Cahill ED. 1971; Acetylsalicylic acid: Inhibition of platelet aggregation in the rabbit. Journal of Pharmacology and Experimental Therapeutics 779: 410
• 24 Roth GJ, Majerus PW. 1975; The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. Journal of Clinical Investigation 56: 624
• 25 Roth GJ, Stanford N, Majerus PW. 1975; Acetylation of prostaglandin synthetase by aspirin. Proceedings of the National Academy of Sciences (USA) 72: 3073
• 26 Snedecor GW, Cochran WG. 1967. Statistical Methods. 6. Iowa State University Press; Ames, Iowa: p 135
• 27 Sofia RD, Diamantis W, Gordon R, Kletzkin M, Berger FM, Edelson J, Singer H, Douglas JF. 1974; Pharmacology of a new non-steroidal anti-inflammatory agent 7-chloro-2- methyl-3,3a-dihydro-2H,9H-isoxazolo [3,2-b] [1,3]-benzoxazin-9-one (W-2395). European Journal of Pharmacology 26: 51
• 28 Sofia RD, Diamantis W, Ludwig BJ. 1975; Comparative anti-inflammatory, analgesic and antipyretic activities of 7-chloro-2-methyl-3,3a-dihydro-2H,9H-isoxazolo [3,2-b] [1,3]-benzoxazin- 9-one and 5-chlorosalicylic acid in rats. Journal of Pharmaceutical Sciences 64: 1321
• 29 Stella L, Donati MB, de Gaetano E. 1975; Bleeding time in laboratory animals. I. Aspirin does not prolong bleeding time in rats. Thrombosis Research 7: 709
• 30 Stuart RK. 1970; Platelet function studies in human beings receiving 300 mg of aspirin per day. Journal of Laboratory and Clinical Medicine 75: 463
• 31 Weiss HJ, Aledort LM, Kochwa S. 1968; The effect of salicylates on the hemostatic properties of platelets in man. Journal of Clinical Investigation 47: 2169